نتایج جستجو برای: decompensated cirrhosis

تعداد نتایج: 30534  

Journal: :hepatitis monthly 0
behzad hajarizadeh the kirby institute, unsw australia, sydney, australia; the kirby institute, unsw australia, sydney, australia. tel: +61-293859208, fax: +61-293850876 devin razavi-shearer center for disease analysis, louisville, colorado, usa shahin merat liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, ir iran; digestive oncology research center, digestive disease research institute, tehran university of medical sciences, tehran, ir iran seyed moayed alavian baqiatallah research center for gastroenterology and liver diseases, baqiatallah university of medical sciences, tehran, ir iran; middle east liver diseases center, tehran, ir iran reza malekzadeh liver and pancreatobiliary diseases research center, digestive diseases research institute, tehran university of medical sciences, tehran, ir iran; digestive oncology research center, digestive disease research institute, tehran university of medical sciences, tehran, ir iran homie razavi center for disease analysis, louisville, colorado, usa

conclusions an increasing burden of hcv-related liver disease is expected in iran under the current diagnosis and treatment levels. increased diagnosis and treatment uptake is required in combination with enhanced treatment efficacy to reduce the hcv burden. the relatively young age of the hcv infected population, provides an opportunity for timely interventions to avert the projected rising hc...

2016
Nina Weiler Stefan Zeuzem Martin-Walter Welker

Chronic hepatitis C is a major reason for development of cirrhosis and hepatocellular carcinoma and a leading cause for liver transplantation. The development of direct-acting antiviral agents lead to (pegylated) interferon-alfa free antiviral therapy regimens with a remarkable increase in sustained virologic response (SVR) rates and opened therapeutic options for patients with advanced cirrhos...

Journal: :Gastroenterology research and practice 2016
Sha Lin QinQin Sun WeiLin Mao Yu Chen

Background. Serum immunoglobulins (Igs) are frequently elevated in patients with chronic liver disease, but currently there is a lack of sufficient data on serum Igs in patients with chronic hepatitis B virus (CHB) infection. This study aimed to evaluate serum IgA, IgG, and IgM levels in patients with HBV-related cirrhosis and to analyze, if altered, immunoglobulin levels that were associated w...

Journal: :Acta biochimica Polonica 2009
Jolanta Zuwała-Jagiełło Monika Pazgan-Simon Krzysztof Simon Maria Warwas

Serum concentrations of advanced oxidation protein products (AOPPs) and glycation end products (AGEs) were assessed with respect to functional compromise of liver, as determined by the Child-Pugh and MELD scores. Patients with decompensated liver cirrhosis (Child-Pugh B and C) exhibited significantly higher serum concentrations of AOPPs than both patients with compensated liver cirrhosis (Child...

2017
Ashish Kumar Jha Sharad Kumar Jha Amarendra Kumar Vishwa Mohan Dayal Sanjeev Kumar Jha

AIM To assess the vitamin D (VD) deficiency as a prognostic factor and effect of replenishment of VD on mortality in decompensated cirrhosis. METHODS Patients with decompensated liver cirrhosis were screened for serum VD levels. A total of 101 VD deficient patients (< 20 ng/mL) were randomly enrolled in two groups: Treatment group (n = 51) and control group (n = 50). Treatment group received ...

2016
Victoria L. Gadd Preya J. Patel Sara Jose Leigh Horsfall Elizabeth E. Powell Katharine M. Irvine

BACKGROUND AND AIMS Liver and systemic inflammatory factors influence monocyte phenotype and function, which has implications for hepatic recruitment and subsequent inflammatory and fibrogenic responses, as well as host defence. METHODS Peripheral blood monocyte surface marker (CD14, CD16, CD163, CSF1R, CCR2, CCR4, CCR5, CXCR3, CXCR4, CX3CR1, HLA-DR, CD62L, SIGLEC-1) expression and capacity f...

Journal: :Gut 1981
R Spinsi G Smith-Laing O Epstein S Sherlock

Twenty-five patients with primary biliary cirrhosis undergoing portal decompression have been followed up for a mean of 51 months. Five patients with decompensated cirrhosis died postoperatively. Overall five year survival of 66% is comparable with that for other forms of cirrhosis but none of the long-term survivors, including three patients with a precirrhotic stage of primary biliary cirrhos...

Journal: :The Professional Medical Journal 2015

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید